SUN, Sept 18%
%%HPP Investigators Meeting
08:00-15:30%%%Taipei Int’l Convention Center
Room 101B, 202A, South Lounge (3F)
MON, Sept 19%
%%Joint Cluster Group Mtg.
07:30-08 :30%
%%C-HPP Poster Session
9:30 - 10:30 & 16:20-17:30%
%%PIC Meeting
THURS, Sept 22%
%%HPP Post-Congress Day
08:30 - 18:00%%%Fleur de Chine Hotel,
Sun Moon Lake, Nantou
(Appendix 5)
HPP Plenary Session I
(Rm 101B: See Appendix 1)

Moderators: Young-Ki Paik & Fernando Corrales

8:00-08:55: Rm 101B
HPP Overview

Chair: Michael Snyder (SSAB Chair)
(C-HPP, B/D-HPP, Bioinformatics, Ab, MS)

09:00-09:30%%%HPP Plenary Lecture 1
Chair: Fernando Corrales
Genomics for HPP
Michael Snyder, Stanford Univ. CA

09:30-10:00%%%HPP Plenary Lecture 2
Chair: Christoph M. Overall
“Emerging Tech” -Small ORF Analysis
Alan Saghatelian, Salk Inst. CA

Coffee Breaks (Sign up the Cluster Meeting)

C- and B/D-HPP separate sessions

C-HPP Session 1

Rm 202A
(Appendix 1, 2)
1. Introduction (YK Paik)
2. Top 50 MP Marathon Challenge (CM Overall)
3. Reports on Missing Protein (Lydie Lane)
Chr 3 T. Nishimura
Chr 10 J. LaBaer
Chr 15 G. Domont
Chr 18 S. N. Naryzhny/A. Archakov
Chr 19 G. Marko-Varga
Chr 22 A. Pandey
Chr X T. Yamamoto
Chr Y G. Hosseini Salekdeh
4. Open Discussion
B/D-HPP Session 1**

10:20-12:30 Rm 101B
1. Extreme conditions proteomics (Eugene Nikolaev)
2. Glycoproteomics (Hisashi Narimatsu)
3. Brain Proteome Project (Peter Nilsson)
4. Cardiovascular Initiative (Maggie Lam & PeiPei Ping)
5. Plasma Initiative (Jochen Schwenk)
6. Food and Nutrition Initiative (Paola Roncada)
7. Diabetes Initiative (Loïc Dayon)
8. Mitochondria Initiative (Mauro Fassano)

HPP Plenary Session II (Appendix 1)
Joint Cluster Group Meeting for C-HPP and B/D-HPP (Rm101B)

12:30-13:10 Lunch

13:10-15:20 Joint Cluster Session

(1). Introduction (5-10 min)

-What is “Cluster Collaboration?” (Appendix 2) (Young-Ki Paik)
Move to each designated room for Break-out session

(2). Break-out Session (120 min)
A. Cancer Cluster Group (Rm 101B): Led by Siqi Liu, Ed Nice & Hui Zhang
International Cancer Collaboration: Australia and US (15 min)
Moonshot Project & Int’l Cancer Proteomics Collaboration
Mark Baker (HUPO President), Phil Robinson (ProCan) and Jerry Lee (NCI Office)
Introduction of B/D-HPP Cancer (20 min)
Hui Zhang and Colleagues
Discussion on the Strategic Points (Appendix 1) (85 min)

B. IVTT Cluster Group (Rm 202A) (120 min)
Led by Gyorgy Marko-Varga Joshua LaBaer
Discussion on the Strategic Points (Appendix 1)

C. Reproductive Disease (South Lounge) (120 min)
Led by Charles Pineau & Ghasem Hosseini Salekdeh
Discussion on the Strategic Points (Appendix 1)
Note: While both Membrane Proteins and Neurodegenerative Disease groups may join one of above groups, they may have their own Cluster meeting (203 and 102) on Monday early morning (07:30-8:30).

15:20 HPP Meeting Ends
Joint Cluster Mtg.
(C- and B/D-HPP)

Membrane Cluster Group (Rm 203)
Neurodegenerative Disease Group (Rm 102)
(subject to change w/o notice)

C-HPP Session 2
C-HPP Poster Session
(Chair: Lydie Lane, Co-Chair: Peter Horvatovich)
(Appendix 3)

09:30-10:30: Session 1
(Even Numbers of Chr. 2, 4, 6, 8, 10, 12, 14, 16,18, 20, 22.+X, Y)
15:30-16:30: Session 2
(Odd Numbers of Chr. 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, Mito)

Poster Awards (Cash Prize and -Award Certificate by HUPO President) will be given to Total 7 Best Outstanding Poster Presenters at the Closing Ceremony.

12:20-13:30%%%C-HPP Session 3

C-HPP PIC Meeting (with Lunch: Rm 202A)

(Appendix 4)
1. Report Session (L. Lane)
2. Approval of Pending. Agenda (YK Paik)
3. Nomination and Election (Chris Overall)
4. Future Plans (2016-19) (YK Paik)

List of Appendices
1. HPP Investigators Meeting Agenda
2. New C-HPP Strategies (Cluster Collaboration &Top 50 MP Marathon and)
3. C-HPP Poster Session Guides
4. C-HPP PIC Meeting Agenda
5. HPP Post-Congress Day Agenda
6. Bioinformatics HUB Program
7. Hotel Reservation Form (Fleur De Chine, Sun Moon Lake)
8. 16th C-HPP Workshop in Brazil
Moderator: Gil Omenn


Joint B/D and C-HPP EC meeting

HPP Update Session:
(1) Highlights from Congress and discussions of B/D, C-HPP, Resource Pillars

(2) Bioinformatics Hub, JPR special issue 2016 and future, experience with HPP MS Guidelines v2.1.

Open discussion about recent strategic successes and strategic planning for next year and for 5 years: aims, directions, changes, deliverables

Coffee Break

HPP Plenary Lecture 3, “Lung Cancer Genomics”, Dr. Sung-Liang Yu, NUT, Taiwan

Reports on the Cluster Meeting (C- & B/D-HPP+CPTAC)
1. Cancer
3. Reproductive Dis
4. Membrane Proteins
5. Neurodegenerative Disease,


HPP Concluding Session
1. SSAB Members’ Feedback, led by Cathy Costello
2. HPP Operations & Communication matters (C. Pineau, C. Borchers)
3. Resources and Funding
4. Publications, including assessment of 2016 JPR special issue.
5. Strategic objectives & planned meetings and workshops, Brazil, 2016, and beyond

Boat Tour with Informal Discussion

Dinner and Social Mixer

Appendix 8

16th C-HPP WORKSHOP in Commemoration with 100thAnniversary of Brazilian Academy of Science, RIO DE JANEIRO, BRAZIL,
DECEMBER 10 – 12, 2016


1. Goals to Achieve

What does the 16th Workshop want to achieve?

  1. Celebrate the 100 years of The Brazilian Academy of Sciences during 2016. The workshop is already incorporated as an official scientific event of the Centennial Anniversary.
  2. Jointly discuss and integrate the Chromosome-centric Human Proteome and the Human Biology Diseases Projects. We hope that all groups will share their ideas on the benefits of the integrated studies of these two Human Proteome Projects.
  3. Present cutting-edge science on disease proteomics and mass spectrometry with impact on diseases and targeted medicine. Plans to invite frontier scientists are under way.
  4. Assessment and evaluation of the first Human Proteome Map.
  5. Other goals of the C-HPP 1st Phase not yet fully addressed are the pursuit of systematic ways for identification of proteoforms and complexes as well as cell & tissue localization
  6. Ask whether is there the need of a distinct data deposition for human proteoforms & complexes?
  7. Begin discussion of phase 2: validation. What actually does this mean? For instance, are we already validating protein existence as gene products when target techniques are used to identify missing proteins?
  8. Science has a strong impact on Society. We propose an open discussion with fellow scientists as well as lay citizens and media on the impact of the Human Proteome Project in our daily life.

2. Preliminary Agenda (Proposed by Rio Team)

  • Integration of the C-HPP with the other projects of Biology and Diseases
  • When would be ready for publication of the first HUPO Human Proteome Map.
  • Personal and Translational Medicine: seeds and fruits of The Human Proteome Project.
  • Are we ready for discussing the preparation of the 2nd Phase of the C-HPP (2018-2022)?
  • Communication with the Public: Deliverables to the public from the project?

*Details on the meeting plan will be available soon at HUPO Web and C-HPP Wiki.

Click here to go the overview of C-HPP activities in HUPO 2016, Taipei. The filled form should be sent to the hotel by email to annie.chiang@ldchotels.com.